Legend Biotech Return on Investment 2019-2022 | LEGN

Current and historical return on investment (ROI) values for Legend Biotech (LEGN) over the last 10 years.
Legend Biotech ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2022-03-31 $-0.37B $0.57B -82.65%
2021-12-31 $-0.38B $0.59B -122.09%
2021-09-30 $-0.32B $0.30B -194.79%
2021-06-30 $-0.30B $0.36B -331.65%
2021-03-31 $-0.26B inf%
2020-12-31 $-0.22B inf%
2020-09-30 $-0.23B inf%
2020-06-30 $-0.19B inf%
2020-03-31 $-0.16B inf%
2019-12-31 $-0.13B inf%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $8.483B $0.090B
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's lead product consist LCAR-B38M/JNJ-4528, which are in clinical stage. Legend Biotech Corporation is based in Cayman Islands.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $163.938B 9.97
Bio-Rad Laboratories (BIO.B) United States $14.121B 30.63
QIAGEN (QGEN) Netherlands $10.718B 16.92
Biohaven Pharmaceutical Holding (BHVN) United States $10.276B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.228B 0.00
Arcus Biosciences (RCUS) United States $1.817B 46.07
Emergent Biosolutions (EBS) United States $1.560B 6.68
Myovant Sciences (MYOV) United Kingdom $1.185B 0.00
Zymeworks (ZYME) Canada $0.306B 0.00
Gelesis Holdings (GLS) United States $0.112B 0.00
Ambrx Biopharma (AMAM) United States $0.102B 0.00
Enzo Biochem (ENZ) United States $0.101B 0.00
SQZ Biotechnologies (SQZ) United States $0.090B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00